Clearance Summary
LIFESIGN MI MYOGLOBIN received FDA 510(k) clearance under submission number K942052, sponsored by Princeton Biomedix. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1995-02-07.
- Submission: K942052
- Applicant / Sponsor: Princeton Biomedix
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5680
- Decision date: 1995-02-07
Classification & Regulation
This clearance is catalogued under FDA product code DDR and 21 CFR 866.5680, within the Immunology review panel as a Class II device.